StockSelector.com
  Research, Select, & Monitor Sunday, May 27, 2018 4:06:27 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
AbbVie Inc.$101.08($2.06)(2.00%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

AbbVie Inc. has an overall rank of 2285 out of 7011 stocks based on 14 positive rankings and 9 negative rankings.

Positive Rankings
Highest ROE
AbbVie Inc. rank is 64
Positive Guidance
Within the past 90 days AbbVie Inc. has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Top Intrinsic Values
AbbVie Inc. rank is 265
Highest Net Margin
AbbVie Inc. rank is 300
Beat Whisper
According to EarningsWhispers.com, AbbVie Inc. beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
PEGValue
AbbVie Inc. has a PEG Value of $131.27. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 29.87% in the next year. Among companies with a PEG Value above the current stock price, AbbVie Inc. is ranked 422.
Estimated EPS Growth
AbbVie Inc. rank is 499
Estimated Revenue Growth
AbbVie Inc. rank is 539
Historic EPS Growth
AbbVie Inc. rank is 861
Highest ROA
AbbVie Inc. rank is 909
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 0.24%. Among companies that have had their estimates raised within the past month, AbbVie Inc. is ranked 917.
SSValue
The StockSelector Value for AbbVie Inc. is $115.85. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, AbbVie Inc. is ranked 1210.
Historic Revenue Growth
AbbVie Inc. rank is 1450
Up EPS Surprise
AbbVie Inc. beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Price-to-Book
AbbVie Inc. rank is 119
Debt-to-Equity
AbbVie Inc. rank is 167
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, AbbVie Inc. is ranked 228.
High Put/Call
AbbVie Inc. has a high Put/Call ratio of 1.04 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, AbbVie Inc. is ranked 556.
High vPut/Call
AbbVie Inc. has a high Put/Call ratio of 0.98 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, AbbVie Inc. is ranked 802.
10 Day Loss
AbbVie Inc. rank is 997
Price-to-Sales
AbbVie Inc. rank is 1016
90 Day Loss
AbbVie Inc. rank is 2151







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.